Medicine NewsPsychiatrist and psychoanalytic psychotherapist John, Lord Alderdice will apply a psychoanalytic perspective to the issues of fundamentalism, radicalization and terrorism at a lecture to be held at the Institute of Psychoanalysis on Friday 12 June 2009, 7.00pm. Lord Alderdice has devoted his working life to the application of psychoanalysis to the [...]
Comments Off
Watching people’s brains in real time as they handle a set of decision-making problems can reveal how different each person’s strategy can be, according to neuroscientists at the Duke University Medical Center. “People in our study, like the population at large, differed in the strategies they use to make economic decisions,” said [...]
Comments Off
Researchers have identified the locking mechanism that allows some neurons to form synapses to pass along essential information. Mutations of genes that produce a critical cell-adhesion molecule involved in the work were previously linked to autism.
Comments Off
A new instrument for improving patient understanding and acceptance of long-acting injectable antipsychotic therapy (LAT) has been published in the April edition of Psychiatry 2009.1 This novel, psychosocial approach encompasses Goal setting, Action planning, Initiating treatment, and Nurturing motivation (GAIN) through the use of a clinical discussion tool.
Comments Off
The atherosclerosis vaccine development program by AFFiRiS AG is receiving financial support from the EU’s EUROTRANS-BIO call. The respective project is being carried out in cooperation with German company EMC microcollections GmbH. The aim of atherosclerosis vaccination is to increase the amount of “good” high density lipoprotein cholesterol (HDLc) in the blood and thus reduce [...]
Comments Off
Competitive Technologies, Inc. (NYSE Amex: CTT) announced today that CTT’s pain therapy medical device will be used by clinical investigators at the Virginia Commonwealth University Massey Cancer Center for a Phase II independent clinical study. The study will examine the ability of CTT’s U.S. FDA-cleared device to decrease pain associated with chemotherapy-induced peripheral neuropathy (CIPN).
Comments Off
FDA on Tuesday posted on its Web site advertising guidelines for drugmakers and medical device manufacturers, offering suggestions on how to present risk information to health care professionals and consumers, the Wall Street Journal reports.
Comments Off